Exploratory associations of composite inflammatory-immune markers with 28-day and 1-year all-cause mortality in patients with sepsis: a retrospective cohort study
5 affiliations
- 1Graduate School, Hebei Medical University
- 2Department of Critical Care Medicine, Hebei General Hospital, Hebei Medical University
- 3Graduate School, Hebei North University
- 4Department of Emergency Medicine and Critical Care Medicine (Ward 2), Hebei General Hospital
- 5Hebei Key Laboratory of Clinical Pharmacy
Abstract
Aims: Inflammation and immune dysregulation are central to sepsis pathobiology, but the prognostic value of a broad panel of composite inflammatory-immune indices remains incompletely defined. We evaluated the associations of 18 composite inflammatory-immune markers with 28-day and 1-year all-cause mortality in sepsis patients.
Methods: This single-center retrospective cohort study included 396 adult patients admitted to the intensive care unit (ICU) with sepsis. Eighteen inflammatory-immune indices were calculated from blood tests obtained within the first 24 h after ICU admission. Per-1-standard deviation (SD) multivariable Cox models were used to evaluate each marker’s association with 28-day and 1-year all-cause mortality. Subgroup analyses were performed by age (<75 vs. ≥75 years), sex, and sepsis-associated acute kidney injury status, with multiplicative interaction terms. Restricted cubic spline (RCS) analyses were used to assess nonlinearity.
Results: Among 396 patients, 174 (43.9%) died within 28 days and 230 (58.1%) died within 1 year. In the primary per-1-SD multivariable Cox analyses, higher C-reactive protein-to-lymphocyte ratio (CLR) and platelet-to-lymphocyte ratio (PLR) were associated with higher 28-day mortality (CLR: HR 1.313, 95% CI 1.145–1.505; P<0.001; PLR: HR 1.253, 95% CI 1.114–1.410; P<0.001) and 1-year mortality (CLR: HR 1.258, 95% CI 1.104–1.435; P<0.001; PLR: HR 1.193, 95% CI 1.071–1.329; P = 0.001). Higher lymphocyte-to-HDL-C ratio (LHR) was inversely associated with both endpoints (28-day: HR 0.759, 95% CI 0.626–0.920; P = 0.005; 1-year: HR 0.819, 95% CI 0.703–0.954; P = 0.010). Other markers showed endpoint-dependent or otherwise variable associations. Most formal interaction tests did not indicate heterogeneity by age, sex, or sepsis-associated acute kidney injury (SA-AKI) status; nominal interactions were observed for pan-immune-inflammation value with age for both endpoints and with SA-AKI status for 1-year mortality. RCS analyses showed nonlinear associations of log ₁₀ -transformed PLR and CLR with both endpoints and an approximately linear inverse association of log ₁₀ -transformed LHR with 28-day mortality.
Conclusions: Higher CLR and PLR and lower LHR were independently associated with both short- and long-term mortality in patients with sepsis. However, the findings were derived from a single-center retrospective cohort without independent validation and do not establish clinical prediction utility. Further multicenter studies are required to validate these markers before they can be considered for clinical risk stratification.
Related
- Composite inflammatory indices and incident lung cancer risk in an exploratory statistical mediation analysis
- Associations of systemic inflammatory indices with rheumatoid arthritis and all-cause mortality: a NHANES study with independent hospital-based replication
- Machine-learning phenotyping and exploratory medication-outcome associations in heart failure with preserved ejection fraction: a multicohort retrospective study
- Associations of serum phosphate levels and intravenous phosphate exposure with mortality in patients with sepsis: a multi-database retrospective study
- Epidural Abscess in Routine Preoperative MRI Reports Versus Documented Operative Findings, and Exploratory Mortality Risk Factors in Surgically Treated Spondylodiscitis: A Retrospective Single-Centre Study
BibTeX
@article{wang2026exploratory,
title = {{Exploratory associations of composite inflammatory-immune markers with 28-day and 1-year all-cause mortality in patients with sepsis: a retrospective cohort study}},
author = {Jiakai Wang and Yaqi Wang and Lei Li and Chenxin Zhang and Kexin Wen and Xiaohong Pi and Kaitian Yao and Quansheng Du},
journal = {Frontiers in Endocrinology},
year = {2026},
month = oct,
doi = {10.3389/fendo.2026.1946659},
url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.1946659/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Exploratory associations of composite inflammatory-immune markers with 28-day and 1-year all-cause mortality in patients with sepsis: a retrospective cohort study
AU - Jiakai Wang
AU - Yaqi Wang
AU - Lei Li
AU - Chenxin Zhang
AU - Kexin Wen
AU - Xiaohong Pi
AU - Kaitian Yao
AU - Quansheng Du
PY - 2026
DA - 2026/10/28
JO - Frontiers in Endocrinology
DO - 10.3389/fendo.2026.1946659
UR - https://www.frontiersin.org/articles/10.3389/fendo.2026.1946659/full
AB - Aims: Inflammation and immune dysregulation are central to sepsis pathobiology, but the prognostic value of a broad panel of composite inflammatory-immune indices remains incompletely defined. We evaluated the associations of 18 composite inflammatory-immune markers with 28-day and 1-year all-cause mortality in sepsis patients. Methods: This single-center retrospective cohort study included 396 adult patients admitted to the intensive care unit (ICU) with sepsis. Eighteen inflammatory-immune indices were calculated from blood tests obtained within the first 24 h after ICU admission. Per-1-standard deviation (SD) multivariable Cox models were used to evaluate each marker’s association with 28-day and 1-year all-cause mortality. Subgroup analyses were performed by age (<75 vs. ≥75 years), sex, and sepsis-associated acute kidney injury status, with multiplicative interaction terms. Restricted cubic spline (RCS) analyses were used to assess nonlinearity. Results: Among 396 patients, 174 (43.9%) died within 28 days and 230 (58.1%) died within 1 year. In the primary per-1-SD multivariable Cox analyses, higher C-reactive protein-to-lymphocyte ratio (CLR) and platelet-to-lymphocyte ratio (PLR) were associated with higher 28-day mortality (CLR: HR 1.313, 95% CI 1.145–1.505; P<0.001; PLR: HR 1.253, 95% CI 1.114–1.410; P<0.001) and 1-year mortality (CLR: HR 1.258, 95% CI 1.104–1.435; P<0.001; PLR: HR 1.193, 95% CI 1.071–1.329; P = 0.001). Higher lymphocyte-to-HDL-C ratio (LHR) was inversely associated with both endpoints (28-day: HR 0.759, 95% CI 0.626–0.920; P = 0.005; 1-year: HR 0.819, 95% CI 0.703–0.954; P = 0.010). Other markers showed endpoint-dependent or otherwise variable associations. Most formal interaction tests did not indicate heterogeneity by age, sex, or sepsis-associated acute kidney injury (SA-AKI) status; nominal interactions were observed for pan-immune-inflammation value with age for both endpoints and with SA-AKI status for 1-year mortality. RCS analyses showed nonlinear associations of log ₁₀ -transformed PLR and CLR with both endpoints and an approximately linear inverse association of log ₁₀ -transformed LHR with 28-day mortality. Conclusions: Higher CLR and PLR and lower LHR were independently associated with both short- and long-term mortality in patients with sepsis. However, the findings were derived from a single-center retrospective cohort without independent validation and do not establish clinical prediction utility. Further multicenter studies are required to validate these markers before they can be considered for clinical risk stratification.
SN - 1664-2392
ER -